Elutia’s Post

We are excited to share the first EluPro antibiotic-eluting BioEnvelope has been implanted in the state of Louisiana by Dr. Kasabali and his team at Willis Knighton medical center.

Today we celebrate one year of Elutia 🎉 and the amazing team that spent the last 365 days working toward our mission of humanizing medicine. Read more about all of our year one milestones here: https://lnkd.in/gMyuuPTT

Our CEO, Randal Mills, and CFO, Matt Ferguson will participate in the H.C. Wainwright 26th Annual Global Investment Conference on September 9th, join the webcast to listen here: https://lnkd.in/gyhM7_nr

We are thrilled to announce that the first EluPro implant was completed today. The groundbreaking procedure was performed by John N. Catanzaro MD, MBA at ECU Health in Greenville, NC. Achieving this milestone demonstrates our commitment to advancing healthcare with innovative solutions. Read more: https://lnkd.in/gQVTYBHv

Watch as Dr. Benjamin D’Souza walks you through a clinical example of the implantation process of CanGaroo Envelope in one of his #CIED patients. https://lnkd.in/gFEX2vZJ #ECM #BiologicHealing #EPeeps

Last week our President and CEO Dr. C. Randal Mills, Ph.D. spoke at the Emerging Growth Conference about our newly FDA approved EluPro product and our vision for Elutia. Watch the full interview here: https://lnkd.in/e2RNvqiG

Join our Elutia team! Are you an experienced Sales Representative, Scientist or Engineer in the medical device space? Check out our openings below and apply: - Development Engineer - Development Scientist - Territory Business Managers Columbus, OH Birmingham, AL Phoenix, Az Philadelphia, PA New Jersey/ New York Chicago, IL Dallas, TX Apply here: https://lnkd.in/gCsy8_5q #jobopenings #medicaldevice #medicaldevicesales

Dr. Jackson Liang at the University of Michigan used CanGaroo on his dual-chamber pacemaker patient. His 4-month post-implant findings? No evidence of active acute inflammation, infection, or necrosis. Read the full histologic case analysis: https://lnkd.in/gmPs9sax #EPeeps #CanGaroo

Join us tomorrow, August 7th at 4:30pm EST for our Q2 2024 financial results webcast. Listen here: https://lnkd.in/gtCuNB-Z